Search

Search Constraints

You searched for: Author/Creator Quarantini, Lucas C.

Search Results

1. Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression. (18th February 2022)

2. Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial. Issue 38 (September 2018)

3. Drugs age-of-onset as a signal of later post-traumatic stress disorder: Bayesian analysis of a census protocol. (February 2022)

4. Effects of GRIN2B, GRIA1, and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial. Issue 6 (11th November 2022)

5. Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression. Issue 4 (21st July 2022)

7. Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review. Issue 2 (March 2022)

8. Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review. Issue 2 (March 2022)

9. Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review. Issue 5 (9th September 2021)

10. Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review. Issue 5 (September 2021)